PACT Grant-in-Aid for Investigator Led Pulmonary Fibrosis Clinical Research
Deadline for applications: midnight 14th February 2021
The Pulmonary Fibrosis Australasian Clinical Trials (PACT) Network is a collaboration uniting the Centre for Research Excellence in Pulmonary Fibrosis, leading pulmonary fibrosis specialists, and Lung Foundation Australia to design and deliver high quality clinical trials and studies that will provide hope and improved outcomes for people living with pulmonary fibrosis.
PACT’s Mission is to reduce the morbidity and mortality associated with pulmonary fibrosis and improve the quality of life for people living with pulmonary fibrosis, their carers and families through the facilitation and coordination of high quality clinical research.
In 2021, there is ONE (1) Grant-in-Aid opportunity valued at up to AUD30,000 to assist investigator led pulmonary fibrosis clinical research. The objective of the PACT Grant-in-Aid is to facilitate high quality clinical research in line with PACT’s Mission Statement (https://pact.lungfoundation.com.au/about-pact/).
The PACT Grant-in-Aid Award is open to Health Professional PACT members (join here - https://pact.lungfoundation.com.au/pact-membership/). Members may apply individually or as part of a group, however collaborative studies are preferred.
Note that these funds can be used to support any stage of clinical research. Funds cannot be used for preclinical research. In most cases, the PACT Grant-in-Aid is not intended to provide sole support for the research activities. Instead it is designed to act as seed money to obtain pilot data to support attracting additional external funding; or as a top up Grant–in-Aid to assist with undertaking a currently funded research project. For example, the Grant-in-Aid funding may be used to support:
Information should also be provided on other sources of project funding and how the Grant would be used if the application were to be successful. Preference will be given to applications which demonstrate most clearly how the Grant-in-Aid will leverage existing funding or significantly enhance the attractiveness of a subsequent grant proposal.
Applications will undergo peer-review with the support of the Thoracic Society of Australia and New Zealand (TSANZ). If during the peer-review process the reviewing committee determine there are no applications of suitable merit, PACT has a right to decline to award the Grant.
The PACT Grant-in-Aid will be offered to an individual or group of individuals meeting the following eligibility criterion:
Applications will be assessed by an independent review committee. The judging criteria for the submitted applications will be:
Originality of idea and impact of study
Feasibility of Project, including Budget
Appropriateness of Methods
Grant in Aid – Application Timelines
10th December 2020
14th February 2021
Applications Close: applications to be submitted via TSANZ portal by end of Sunday 14th February
Review period for applications and correspondence with applicants if required
30th April 2021
Notification of successful applicant
1-2 May 2021
Official recognition of award recipient – TSANZSRS 2021
Dr Alison Hey-Cunningham
Project Manager, Centre of Research Excellence in Pulmonary Fibrosis
The University of Sydney